Position
Squarepoint Ops LLC in Verrica Pharmaceuticals Inc.
Back to the book · All holders of VRCA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$100.5K$8.31 → $5.29
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 33.3K | $276.5K | — | — | — | 0.0% |
| Q1 2026 | 75.2K | $397.9K | $5.29 | −$100.5K | $221.9K | 0.0% |